Rankings
▼
Calendar
RNA (Avidity Biosciences, Inc.) Stock Financials & Earnings | Market Cap Arena
RNA
Avidity Biosciences, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$19M
Net Income (TTM)
-$685M
EPS (TTM)
-$4.97
Free Cash Flow (TTM)
-$667M
Gross Margin
-644.4%
Op. Margin
-3977.3%
Net Margin
-3650.4%
FCF Margin
-3556.0%
P/S Ratio (TTM)
123.6x
P/E Ratio (TTM)
—
YoY Rev Growth
+72.1%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$2M
-$46M
-$58M
Q2 23
$2M
-$40M
-$53M
Q3 23
$3M
-$45M
-$59M
Q4 23
$2M
$2M
-$67M
Q1 24
$4M
$3M
-$77M
Q2 24
$2M
$1M
-$83M
Q3 24
$2M
$2M
-$98M
Q4 24
$3M
$3M
-$121M
Q1 25
$2M
$2M
-$132M
Q2 25
$4M
-$134M
-$171M
Q3 25
$12M
$12M
-$189M
Q4 25
$860K
-$636K
-$254M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
239.8x
—
Q2 23
236.4x
—
Q3 23
228.6x
—
Q4 23
242.4x
—
Q1 24
213.2x
—
Q2 24
218.6x
—
Q3 24
229.0x
—
Q4 24
212.6x
—
Q1 25
259.6x
—
Q2 25
216.0x
—
Q3 25
111.0x
—
Q4 25
123.6x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$49M
-$51M
Q2 23
-$50M
-$50M
Q3 23
-$37M
-$38M
Q4 23
$17M
$16M
Q1 24
-$70M
-$71M
Q2 24
-$65M
-$66M
Q3 24
-$66M
-$67M
Q4 24
-$100M
-$104M
Q1 25
-$125M
-$129M
Q2 25
-$200M
-$203M
Q3 25
-$156M
-$160M
Q4 25
-$170M
-$175M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$622K
Q3 23
$923K
Q4 23
$863K
Q1 24
$915K
Q2 24
$531K
Q3 24
$2M
Q4 24
$4M
Q1 25
$4M
Q2 25
$3M
Q3 25
$4M
Q4 25
$6M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+24.4%
+65.0%
Q2 23
+6.3%
+13.4%
Q3 23
+13.5%
+29.6%
Q4 23
-20.8%
+23.1%
Q1 24
+58.7%
+34.9%
Q2 24
-11.7%
+54.1%
Q3 24
-17.1%
+63.5%
Q4 24
+35.6%
+79.8%
Q1 25
-55.6%
+64.9%
Q2 25
+88.1%
+106.7%
Q3 25
+434.0%
+100.3%
Q4 25
-71.1%
+106.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$9M
407.7%
Q2 23
$9M
408.2%
Q3 23
$10M
348.5%
Q4 23
$10M
448.9%
Q1 24
$10M
290.9%
Q2 24
$13M
626.5%
Q3 24
$14M
603.3%
Q4 24
$14M
476.1%
Q1 25
$18M
1127.5%
Q2 25
$18M
459.0%
Q3 25
$19M
152.5%
Q4 25
$43M
5048.7%
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$48M
$12M
Q2 23
$43M
$12M
Q3 23
$48M
$14M
Q4 23
$53M
$16M
Q1 24
$67M
$14M
Q2 24
$64M
$21M
Q3 24
$77M
$23M
Q4 24
$96M
$28M
Q1 25
$99M
$34M
Q2 25
$138M
$37M
Q3 25
$155M
$46M
Q4 25
$167M
$89M
marketcaparena.com
Revenue Segments
Reportable Segment
Quarter
Reportable Segment
Q1 25
$2M
Q2 25
$4M
Q3 25
$12M
Q4 25
$860K
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$119M
$468M
$586M
Q2 23
$154M
$423M
$577M
Q3 23
$86M
$457M
$543M
Q4 23
$185M
$410M
$595M
Q1 24
$471M
$444M
$916M
Q2 24
$576M
$723M
$1.3B
Q3 24
$370M
$1.2B
$1.6B
Q4 24
$220M
$1.3B
$1.5B
Q1 25
$254M
$1.1B
$1.4B
Q2 25
$244M
$939M
$1.2B
Q3 25
$350M
$1.5B
$1.9B
Q4 25
$383M
$1.3B
$1.7B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
70M
+22.9%
Q2 23
71M
+1.4%
Q3 23
74M
+3.8%
Q4 23
76M
+2.6%
Q1 24
87M
+14.7%
Q2 24
107M
+22.6%
Q3 24
123M
+15.4%
Q4 24
128M
+4.2%
Q1 25
129M
+0.6%
Q2 25
130M
+0.3%
Q3 25
138M
+6.4%
Q4 25
138M
-0.1%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$83K
82
FY 21
$75K
125
FY 22
$50K
186
FY 23
$38K
253
FY 24
$28K
391
FY 25
$37K
511
marketcaparena.com